Application of carbohydrate array technology to antigen discovery and vaccine development.
about
Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccinesAn array-based method to identify multivalent inhibitors.Glycoarrays with engineered phages displaying structurally diverse oligosaccharides enable high-throughput detection of glycan-protein interactionsMAb L9E10 to blood group H2 antigen binds to colon cancer stem cells and inhibits tumor cell migration and invasion.Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray.Effects of hapten density on the induced antibody repertoireRealizing the Promise of Chemical Glycobiology.Improved procedure for direct coupling of carbohydrates to proteins via reductive aminationContext-specific target definition in influenza a virus hemagglutinin-glycan receptor interactionsMicroarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies.Profiling human serum antibodies with a carbohydrate antigen microarray.Chemoenzymatic synthesis and lectin array characterization of a class of N-glycan clusters.GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.Parasite glycans and antibody-mediated immune responses in Schistosoma infection.Cancer stem cell marker glycosylation: Nature, function and significance.Multiplex glycan bead array for high throughput and high content analyses of glycan binding proteins.Genetically-encoded fragment-based discovery (GE-FBD) of glycopeptide ligands with differential selectivity for antibodies related to mycobacterial infections.DNA glycoclusters and DNA-based carbohydrate microarrays: From design to applications
P2860
Q33431143-FEEA7F0B-59BA-440C-9BC2-F3E16E04AF3FQ34073845-FAF85A53-501D-42BA-8D09-0713A5EE8FE2Q35039981-5380890A-A84C-4444-9B0B-097B134EB372Q35095509-3921815C-7E6A-421A-A738-A1B917FC5A81Q36278684-77C7116C-E2B0-48CF-A3EA-D8D9A94AD80BQ36292042-E3943FDF-88DC-47E0-8962-E56B9FA70188Q37063821-8316C18E-2501-4120-905C-9E2AEFA0D17DQ37069271-1B4E8A95-7FDB-44FC-AECD-EC96928FCFAAQ37069489-568EF564-C78F-4367-A639-3CF7D0D4F9D5Q37315367-61508B1E-CF64-4795-90B9-009C5D70FF2BQ37335054-C9B33611-8A9F-4CD0-85F3-5BA6EA98ECCCQ37468164-BAAC5F34-3230-411B-9B57-C6BF8ACD7D13Q37480147-FA74F1C0-E862-4ED9-95CE-54B5871C439DQ37512647-EF8767B9-78A7-45E5-B012-11B73656B824Q37994231-50C0816C-F45F-4902-95E4-E8763748FE6FQ39380552-5A9D87DB-5D27-4CAB-A9F3-5664BB7D4D97Q49870857-ED364E18-4131-404C-8E5B-14F83CF1A285Q54299149-898DC89D-43F9-4EEB-A25B-22767A1B4702Q56789146-D4440E34-2FDA-483E-A622-AF908D722F36
P2860
Application of carbohydrate array technology to antigen discovery and vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Application of carbohydrate ar ...... overy and vaccine development.
@en
Application of carbohydrate ar ...... overy and vaccine development.
@nl
type
label
Application of carbohydrate ar ...... overy and vaccine development.
@en
Application of carbohydrate ar ...... overy and vaccine development.
@nl
prefLabel
Application of carbohydrate ar ...... overy and vaccine development.
@en
Application of carbohydrate ar ...... overy and vaccine development.
@nl
P2860
P356
P1476
Application of carbohydrate ar ...... overy and vaccine development.
@en
P2093
Jeffrey C Gildersleeve
Oyindasola Oyelaran
P2860
P304
P356
10.1586/14760584.6.6.957
P577
2007-12-01T00:00:00Z